ERS Presidential Summit on breaking down barriers to lung health, Rome 2014

About
Research Seminars gather a small number (20 to 100) of well-established and preferably young investigators to address scientific topics in depth and help break new ground. Research Seminars take place over two days in easy-to-reach European cities. They are scientific Seminars involving recently published work and research in progress. Participation is fully supported by the budget granted by the ERS.
About  Show

Background
ERS Presidential Summits are a forum for discussion in the interface between science and policy. The 2014 Presidential Summit hosted speakers from a range of fields, from policymakers to researchers and patients, coming together to discuss key issues in medicine development. More specifically the objectives of the 2014 Summit were to examine the various barriers to new medical products, from research to regulatory issues, and explore new ways to create a better environment for medicine development.
Background  Show

Download all media Download all media
 [+]  PDF journal article, handout or slides Slide presentation Introduction
P.J. Barnes (London, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Better animal models of respiratory disease?
M. Belvisi (London, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Alternatives to animal studies: virtual lung, human cells, in silico?
A. Holmes (London, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Italian Presidency of the EU: health priorities
M. Marletta (Rome, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation Revised EU directive clinical trials
F. Meunier (Brussels, Belgium)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation National example: Italian Medicines' Agency
L. Pani (Rome, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation Innovative Medicines Initiatives (IMI)
N. Seigneuret (Brussels, Belgium)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation A national example: German Centre for Lung Research
W. Seeger (Giessen, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides The Alliance for biomedical research in Europe
K. Sipido (Leuven, Belgium)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation 10 Regulatory aspects of respiratory drugs
S. Bonini (London, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation 11 Benefit versus risk of innovation for industry
R. Strieter (Cambridge, United States of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation 12 Case study in cystic fibrosis: the US CF Foundation research and clinical development programmes
T. Ferkol (St. Louis, United States of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation 13 Patient's perspective I
K. Hansen (Denmark)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Slide presentation 14 Patient's perspective II
F. Buccella (Rome, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  PDF journal article, handout or slides Slide presentation 15 Bench to bedside: what are the impediments to translational research
M. Rawlins (London, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite